Waste disposal protein is mechanism behind cancer tumor suppressionJune 12, 2009Team at the Cancer Institute of New Jersey and Rutgers University focuses on cell self digestion pathway New Brunswick, N.J. - "Taking out the trash" takes on a whole new meaning, as investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, have discovered that a waste disposal protein is the key to cancer tumor suppression in a process known as autophagy. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. Autophagy is a process in which cancer cells eat themselves. Previous study from the lab of Eileen White, PhD, associate director for basic science at CINJ, and a number of other groups has shown that autophagy is a pathway to cancer tumor suppression, but scientists did not know the mechanism behind it, until now. The latest research, which appears in this week's print and online editions of Cell, focuses on a protein known as p62. This protein is responsible for disposing of damaged proteins that accumulate in a cell when it is no longer receiving nourishment for growth and is under other environmental stress. In order for cells to prevent themselves from becoming a cancer tumor, they need to rid themselves of this waste. The p62 protein packages the damaged materials and prepares these materials, along with itself, to be degraded through the autophagy process. Disruption in the process or failure to dispose of p62 from the cell can result in toxicity, genome damage and inflammation, which in turn can promote tumor progression. Dr. White, who is an adjunct professor of surgery at UMDNJ-Robert Wood Johnson Medical School, and a professor of molecular biology and biochemistry at Rutgers University, is the senior author of the research publication. She notes this is the first time the disposal of p62 has been linked with tumor suppression, which can be key in cancer prevention. "This discovery is important, because we now have an opportunity to look at people at risk for cancer before it develops," she notes. "These latest findings show that p62 can act as a marker to identify certain cancers and that we can manipulate p62 levels to stimulate the process of autophagy and ultimately tumor suppression." The team looked at both mouse models and human tissue samples from liver, lung and kidney tumors. White indicates there is evidence that controlling p62 levels also has implications in lymphoma and breast and prostate cancers. And because diseases such as Alzheimer's, Parkinson's and Huntington's share the same property of failing to dispose of protein waste properly, White says this latest discovery involving the p62 protein also has implications for further unlocking the mysteries of neurodegenerative disorders and for providing tools for new drug discovery. Many current cancer treatments also activate the process of autophagy. White notes further understanding of the p62 mechanism in relation to this functional consequence is necessary, as induction of autophagy during treatment can be counterproductive. White notes subsequent study should include trying to identify new or existing drugs that will enhance the autophagy process so that novel mechanisms for tumor prevention can be established. Rutgers University |
|||||||||||||||||||||
| Related Autophagy Current Events and Autophagy News Articles Inhibitor of heat shock protein is a potential anticancer drug, Penn study finds Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals - all can wreak havoc on the delicate internal components of a cell, potentially damaging it beyond repair. HIV uses autophagy for its own means Not satisfied with simply thwarting its host's defensive maneuvers, HIV actually twists one to its advantage, based on new findings from Kyei et al. in the July 27, 2009 issue of the Journal of Cell Biology (www.jcb.org). Vojo Deretic and colleagues suggest that autophagy-a stress response process-helps HIV to proliferate and that conversely, blocking autophagy lessens HIV production. Scientists advance safety of nanotechnology Scientists have identified for the first time a mechanism by which nanoparticles cause lung damage and have demonstrated that it can be combated by blocking the process involved, taking a step toward addressing the growing concerns over the safety of nanotechnology. Muscle atrophy through thick but not thin During desperate times, such as fasting, or muscle wasting that afflicts cancer or AIDS patients, the body cannibalizes itself, atrophying and breaking down skeletal muscle proteins to liberate amino acids. Enhancing the effects of the drug used to treat chronic myeloid leukemia Individuals with chronic myeloid leukemia (CML) are first treated with a drug known as imatinib mesylate. Although very effective, as the disease progresses it often becomes resistant to the drug. Therapeutic effect of imatinib improved with addition of chloroquine The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported in the Journal of Clinical Investigation. TB breakthrough could lead to stronger vaccine A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine's Advance Online Publication March 1. Self-digestion as a means of survival In times of starvation, cells tighten their belts: they start to digest their own proteins and cellular organs. The process - known as autophagy - takes place in special organelles called autophagosomes. Helicobacter pylori can multiply in autophagic vesicles Helicobacter pylori, a Gram-negative, flagellated, microaerophilic bacterium, can selectively colonize in the human stomach. Its infection is widespread throughout the world, and is present in about 50% of the global human population with 80% in developing countries and 20-50% in industrialized countries. Toxicity mechanism identified for Parkinson's disease Neurologists have observed for decades that Lewy bodies, clumps of aggregated proteins inside cells, appear in the brains of patients with Parkinson's disease and other neurodegenerative diseases. More Autophagy Current Events and Autophagy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||